UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation - PubMed (original) (raw)
UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation
Asami Mori et al. Drug Metab Dispos. 2005 May.
Abstract
The UDP-glucuronosyltransferase (UGT) family plays a major role in the excretion of endobiotics and xenobiotics and their metabolites. Human UGT1A4 catalyzes the glucuronidation of primary, secondary, and tertiary amines, sapogenins, androgens, and progestins. We directly sequenced polymerase chain reaction-amplified fragments of the UGT1A4 gene from 100 healthy adult Japanese volunteers and calculated their mutation frequency. We identified four single nucleotide polymorphisms (SNPs): three in exon 1 (142T > G: L48V, 448T > C: L150L, 804G > A: P268P), and one in intron 1 (867 + 43C > T). We found three types of alleles with distinct SNP combinations that coded for different amino acid sequences: L48V-L150L-P268P-867 + 43C > T (frequency, 0.155), L48V (0.01), and P268P (0.01) (wild-type frequency was 0.825). The L48V mutant gave twice the efficiency (V(max)/K(m)) for the antipsychotic drug clozapine as the wild-type. Efficiencies of L48V for trans-androsterone, imipramine, and cyproheptadine were increased, but the efficiency for tigogenin was reduced. L48V therefore increased or decreased the glucuronidation activity, depending upon the substrates. This study shows the importance of identifying patients with the L48V polymorphism when calculating dosage, and when considering the potential adverse effects of drugs that are substrates of UGT1A4.
Similar articles
- Genetic variations and haplotypes of UGT1A4 in a Japanese population.
Saeki M, Saito Y, Jinno H, Sai K, Hachisuka A, Kaniwa N, Ozawa S, Kawamoto M, Kamatani N, Shirao K, Minami H, Ohtsu A, Yoshida T, Saijo N, Komamura K, Kotake T, Morishita H, Kamakura S, Kitakaze M, Tomoike H, Sawada J. Saeki M, et al. Drug Metab Pharmacokinet. 2005 Apr;20(2):144-51. doi: 10.2133/dmpk.20.144. Drug Metab Pharmacokinet. 2005. PMID: 15855727 - Glucuronidation of the second-generation antipsychotic clozapine and its active metabolite N-desmethylclozapine. Potential importance of the UGT1A1 A(TA)₇TAA and UGT1A4 L48V polymorphisms.
Erickson-Ridout KK, Sun D, Lazarus P. Erickson-Ridout KK, et al. Pharmacogenet Genomics. 2012 Aug;22(8):561-76. doi: 10.1097/FPC.0b013e328354026b. Pharmacogenet Genomics. 2012. PMID: 22565219 Free PMC article. - Functional analysis of UGT1A4(P24T) and UGT1A4(L48V) variant enzymes.
Zhou J, Argikar UA, Remmel RP. Zhou J, et al. Pharmacogenomics. 2011 Dec;12(12):1671-9. doi: 10.2217/pgs.11.105. Epub 2011 Nov 2. Pharmacogenomics. 2011. PMID: 22047493 - Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation.
Burchell B. Burchell B. Am J Pharmacogenomics. 2003;3(1):37-52. doi: 10.2165/00129785-200303010-00006. Am J Pharmacogenomics. 2003. PMID: 12562215 Review. - Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins.
Green MD, Tephly TR. Green MD, et al. Drug Metab Dispos. 1998 Sep;26(9):860-7. Drug Metab Dispos. 1998. PMID: 9733664 Review.
Cited by
- mRNA transcript diversity creates new opportunities for pharmacological intervention.
Barrie ES, Smith RM, Sanford JC, Sadee W. Barrie ES, et al. Mol Pharmacol. 2012 May;81(5):620-30. doi: 10.1124/mol.111.076604. Epub 2012 Feb 7. Mol Pharmacol. 2012. PMID: 22319206 Free PMC article. Review. - Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients.
Ghotbi R, Mannheimer B, Aklillu E, Suda A, Bertilsson L, Eliasson E, Osby U. Ghotbi R, et al. Eur J Clin Pharmacol. 2010 May;66(5):465-74. doi: 10.1007/s00228-009-0783-8. Epub 2010 Feb 9. Eur J Clin Pharmacol. 2010. PMID: 20143052 - Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China.
Chang Y, Yang LY, Zhang MC, Liu SY. Chang Y, et al. Eur J Clin Pharmacol. 2014 Aug;70(8):941-6. doi: 10.1007/s00228-014-1690-1. Epub 2014 May 13. Eur J Clin Pharmacol. 2014. PMID: 24820767 Clinical Trial. - The association of genetic polymorphisms in CYP1A2, UGT1A4, and ABCB1 with autonomic nervous system dysfunction in schizophrenia patients treated with olanzapine.
Hattori S, Suda A, Miyauchi M, Shiraishi Y, Saeki T, Fukushima T, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Moritani T, Saigusa Y, Kishida I. Hattori S, et al. BMC Psychiatry. 2020 Feb 18;20(1):72. doi: 10.1186/s12888-020-02492-5. BMC Psychiatry. 2020. PMID: 32070304 Free PMC article. - Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation.
Li H, Wang Q, Li S, Jia C. Li H, et al. Genet Res (Camb). 2022 Sep 28;2022:2917881. doi: 10.1155/2022/2917881. eCollection 2022. Genet Res (Camb). 2022. PMID: 36245555 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases